We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
8 result(s) found, displaying 1 to 8
-
Cancellation by sponsorRequested by PPD Australia Pty Ltd
-
Australian public assessment report (AusPar)Erwinase (crisantaspase) has been approved for the treatment of acute lymphoblastic leukemia as a component of a multi-agent chemotherapeutic regimen for patients who have developed hypersensitivity to pegylated asparaginase.
-
Prescription medicine decision summaryErwinase (crisantaspase) has been approved as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have developed hypersensitivity to pegylated asparaginase obtained from E. coli.
-
Prescription medicine registrationActive ingredients: crisantaspase.
-
Australian public assessment report (AusPar)Nuceiva (prabotulinum toxin A) is indicated for the temporary improvement in appearance of glabellar lines.
-
Prescription medicine decision summaryNuceiva (prabotulinumtoxinA) is approved to treat glabellar lines.
-
Prescription medicine registrationActive ingredients: prabotulinumtoxinA.
-